𝔖 Bobbio Scriptorium
✦   LIBER   ✦

OL-010 Sequential use of nitazoxanide (NTZ) as a salvage therapy in patient with recurrent mild to moderate Clostridium difficile infection (CDI): a prospective, open-label, randomized clinical trial

✍ Scribed by P.P. Basu; N.J. Shah; N. Krishnaswamy; R. Korapati; S. Tammisetti; C.C. Tang


Book ID
118617348
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
45 KB
Volume
14
Category
Article
ISSN
1201-9712

No coin nor oath required. For personal study only.